Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cygnus GlucoWatch

This article was originally published in The Gray Sheet

Executive Summary

Final assembly of the wristwatch-like non-invasive glucose monitoring system at the firm's own manufacturing facility gains FDA go-ahead via PMA supplement, announced Nov. 1. The Redwood City, California company received approval for large-scale manufacturing of the system's consumable AutoSensor component by supplier Corium in August (1"The Gray Sheet" Aug. 13, 2001, In Brief). The device itself was approved in March and Cygnus expects a full-scale launch in the U.S. during the first quarter of 2002. The firm notes it is "in advanced stages of negotiation with multiple companies for a sales alliance"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT015639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel